Income statement
CAD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 11K | 0 | 0 | 0 | 0 |
| Gross Profit | 11K | 0 | -377K | -656K | -327K |
| Operating Income | -6M | -2M | -4M | -14M | -3M |
| EBITDA | -8M | -3M | 0 | 0 | 0 |
| Net Income | -8M | -4M | -4M | -14M | -3M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.4205
+5.09% today
Window Change
+24.88%
Window
Jun 26, 2025 → May 21, 2026
Coverage: 228 bars · Jun 26, 2025 → May 21, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rocket Doctor AI Inc. (AIRDF) is a Healthcare stock with a market cap of $35.73M and listed on OTC. The stock last traded around $0.42 and up 24.9% across the available one-year price window (Jun 26, 2025 → May 21, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +26.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.9%, free cash flow -500.0% with operating margin -1395.3% and ROIC -59.8%. Valuation already assumes a fairly strong business story at price/sales 111.0. Stock Foundry combines AIRDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
AIRDF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
AIRDF Max Drawdown
-45.91%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for AIRDF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$2.9M
+79.0% YoY
Free Cash Flow
-$2.0M
+68.0% YoY
Revenue Growth
+0.0%
EPS Growth
+26.9%
Gross Margin
89.2%
Net Margin
-1382.0%
Income statement
CAD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 11K | 0 | 0 | 0 | 0 |
| Gross Profit | 11K | 0 | -377K | -656K | -327K |
| Operating Income | -6M | -2M | -4M | -14M | -3M |
| EBITDA | -8M | -3M | 0 | 0 | 0 |
| Net Income | -8M | -4M | -4M | -14M | -3M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1M | 716K | 2K | 917K | 313K |
| Total Assets | 1M | 739K | 14K | 943K | 313K |
| Total Liabilities | 486K | 1M | 2M | 833K | 576K |
| Shareholder Equity | 793K | -738K | -2M | 110K | -263K |
| Total Debt | 152K | 585K | 566K | 0 | 0 |
| Net Debt | -1M | -131K | 564K | -917K | -313K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
+68.0% YoY
Capital Expenditures
0
-100.0% YoY
Free Cash Flow
2M
+68.0% YoY
Key ratios
Gross Margin
89.2%
Operating Margin
-1395.3%
Net Margin
-1382.0%
ROE
-190.3%
Debt / Equity
0.08x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.